Loengard Anna U
- SEC CIK
- 0001952723
No open-market purchases or sales filed in the past year.
Current role at each company
- CLOV Clover Health Investments, Corp.Directoras of Jan 8, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Loengard Anna U as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2025 (view filing) | Aug 13 | 1 day | Loengard Anna UDirector | PPurchaseClass A Common Stock | +26.5K | $2.59 | +$68.8K | +852.1%29.6K after | 2 lots |
| May 20, 2024 (view filing) | May 16-17 | 4 days | Loengard Anna UDirector | PPurchaseClass A Common Stock | +27.1K | $0.9478 | +$25.7K | New position15.1K after | 3 lots |
| Mar 18, 2024 (view filing) | Mar 14 | 4 days | Loengard Anna UDirector | PPurchaseClass A Common Stock | +137.0K | $0.73 | +$100.0K | +34.1%538.8K after | |
| Mar 18, 2024 (view filing) | Mar 14 | 4 days | Loengard Anna UDirector | PPurchaseClass A Common Stock | +13.6K | $0.73 | +$9.95K | +908.3%15.1K after | |
| Sep 8, 2023 (view filing) | Sep 6 | 2 days | Loengard Anna UDirector | PPurchaseClass A Common Stock | +11.0K | $1.30 | +$14.3K | New position1.50K after | 3 lots |